OBJECTIVE	This study sought to evaluate the safety and efficacy of the Lutonix drug-coated balloon ( DCB ) coated with 2 g/mm ( 2 ) paclitaxel and a polysorbate/sorbitol carrier for treatment of femoropopliteal lesions .\